Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Solventum Corporation

Solventum Corporation (SOLV) Stock Overview

Explore Solventum Corporation’s financial performance, market position, analyst ratings, and future outlook.

SOLV●NYSE
HealthcareMedical - Instruments & Supplies
$88.61
$0.80(0.91%)
U.S. Market opens in 15h 40m

Solventum Corporation (SOLV)

Meyka AI Score

Z

Key Financials

Market Cap15.3B
P/E Ratio10.70
EPS (TTM)$7.10
ROE0.29%
Fundamental Analysis

AI Price Forecasts

1 Month$85.54
3 Months$78.06
1 Year Target$83.92

SOLV Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Solventum Corporation (NYSE: SOLV) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Solventum Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SOLV on the NYSE shows an RSI of 62.30, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $83.92 for the NYSE listing.

Key metrics behind Solventum Corporation's NYSE-traded stock include a P/E ratio of 10.70 and a market capitalization of 15.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of SOLV on the NYSE.

Price Performance (NYSE: SOLV)

1-Day Change
0.88%
5-Day Change
2.83%
1-Month Change
11.77%
3-Month Change
16.35%
6-Month Change
21.44%
Year-to-Date (YTD) Change
11.79%
1-Year Change
21.59%
3-Year Change
10.72%
5-Year Change
10.72%
All-Time (Max) Change
10.72%

Contact Information

https://www.solventum.com
651-733-1110
1750 Yankee Doodle Road, Eagan, MN, 55121

Company Facts

205,840 Employees
IPO DateApr 1, 2024
CountryUS
Actively Trading

Frequently Asked Questions